Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

  1. Castilla-Rodríguez, I. 12
  2. Cela, E. 3
  3. Vallejo-Torres, L. 24
  4. Valcárcel-Nazco, C. 245
  5. Dulín, E. 3
  6. Espada, M. 6
  7. Rausell, D. 7
  8. Mar, J. 48
  9. Serrano-Aguilar, P. 249
  1. 1 Universidad de La Laguna
    info

    Universidad de La Laguna

    San Cristobal de La Laguna, España

    GRID grid.10041.34

  2. 2 Centre for Biomedical Research of the Canary Islands (CIBICAN)
  3. 3 Hospital General Universitario Gregorio Marañón
    info

    Hospital General Universitario Gregorio Marañón

    Madrid, España

    GRID grid.410526.4

  4. 4 Health Services Research on Chronic Patients Network (REDISSEC)
  5. 5 Canary Islands Foundation for Health Research (FUNCANIS)
  6. 6 Public Health Laboratory, Basque Government
  7. 7 Hospital Universitario La Fe
    info

    Hospital Universitario La Fe

    Valencia, España

    GRID grid.84393.35

  8. 8 Clinical Management Service, Alto Deba Hospital
  9. 9 HTA Unit of the Canary Islands Health Service (SESCS)
Journal:
Expert Opinion on Orphan Drugs

ISSN: 2167-8707

Year of publication: 2016

Volume: 4

Issue: 6

Pages: 567-575

Type: Article

Export: RIS
DOI: 10.1080/21678707.2016.1179572 SCOPUS: 2-s2.0-84975222050 GOOGLE SCHOLAR
Data source: Scopus